FMS vs. ZBH: Fresenius Medical Care vs. Zimmer Biomet Stock Comparison

Company Profile

Fresenius Medical Care (FMS) and Zimmer Biomet (ZBH) both fall under the Health Care Equipment & Services industry group, but FMS is classified in Health Care Providers & Services while ZBH is classified in Health Care Equipment & Supplies.

Zimmer Biomet (ZBH) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Fresenius Medical Care (FMS) at 7.84% and Zimmer Biomet (ZBH) at 6.03% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Both Fresenius Medical Care (FMS) at 4.22% and Zimmer Biomet (ZBH) at 8.95% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Zimmer Biomet (ZBH) at 17.35% operates in the top operating margin quartile, ahead of Fresenius Medical Care (FMS) at 9.63%, which runs around its industry’s norm.

Profitability Metrics

Growth

Zimmer Biomet (ZBH) at 7.20% is around its peer norm for revenue growth, while Fresenius Medical Care (FMS) at 1.51% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Fresenius Medical Care (FMS) at 83.61% sits in the top EPS growth quartile, while Zimmer Biomet (ZBH) at -19.86% is closer to the peer norm — faster per-share earnings growth for FMS.

Growth Metrics

Financial Strength

Zimmer Biomet (ZBH) at 1.46 keeps current ratio within its industry’s typical mid-range, while Fresenius Medical Care (FMS) at 0.99 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for FMS.

Both Fresenius Medical Care (FMS) at 0.79 and Zimmer Biomet (ZBH) at 0.60 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Both Fresenius Medical Care (FMS) at 6.30% and Zimmer Biomet (ZBH) at 0.90% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both Fresenius Medical Care (FMS) at 50.14% and Zimmer Biomet (ZBH) at 24.24% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

Dividend Metrics

Valuation

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while Zimmer Biomet (ZBH) at 26.66 is closer to its industry’s usual earnings multiple — a discount for FMS, though growth and earnings durability still matter.

Fresenius Medical Care (FMS) at 0.62 sits in the cheaper P/S ratio quartile while Zimmer Biomet (ZBH) at 2.33 prices around its industry’s middle — FMS costs less per dollar of sales, though read it alongside growth and margins.

Relative to net asset value, both Fresenius Medical Care (FMS) at 0.85 and Zimmer Biomet (ZBH) at 1.58 look inexpensive, sitting in the lower P/B ratio quartile of their industries.

Valuation Metrics